$18.03
+0.59 (+3.38%)
Open$17.57
Previous Close$17.44
Day High$18.28
Day Low$17.08
52W High$21.27
52W Low$5.95
Volume—
Avg Volume2.86M
Market Cap3.97B
P/E Ratio—
EPS$-1.57
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+261.8% upside
Current
$18.03
$18.03
Target
$65.23
$65.23
$47.67
$65.23 avg
$99.61
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 19.73M | 8.30M | 220.69M |
| Net Income | -355,159,251 | -252,156,044 | 45.13M |
| Profit Margin | -1,800.6% | -3,206.0% | 20.5% |
| EBITDA | -384,320,530 | -289,236,526 | 96.01M |
| Free Cash Flow | — | — | 41.24M |
| Rev Growth | +123.3% | +48.9% | +11.7% |
| Debt/Equity | — | — | 0.55 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $291.31 | +1.07% | 49.3 | 509.50B |
| AMGN | Amgen Inc | $460.42 | +0.03% | 26.5 | 248.84B |
| GILD | Gilead Sciences Inc | $166.89 | -0.41% | — | 208.28B |
| VRTX | Vertex Pharmaceuticals Inc | $547.09 | +0.85% | 34.5 | 137.12B |
| REGN | Regeneron Pharmaceuticals | $904.35 | +0.16% | 19.4 | 93.39B |
| ALNY | Alnylam Pharmaceuticals Inc | $155.94 | -0.46% | 7.7 | 20.98B |